Literature DB >> 17493426

Managing conflict of interest in clinical practice.

Michael Camilleri1, Denis A Cortese.   

Abstract

Conflict of interest, even the appearance of potential conflict, has long been a concern for physicians and scientists. Conflict of interest arises when an activity is accompanied by a divergence between personal or institutional benefit when compared to the responsibilities to patients and to society; it arises in the context of research, purchasing, leadership, and investments. Conflict of interest is of concern because it compromises the trust of the patient and of society in the individual physician or the medical center.

Entities:  

Mesh:

Year:  2007        PMID: 17493426     DOI: 10.4065/82.5.607

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  7 in total

1.  The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Authors:  O Bruyere; J A Kanis; M-E Ibar-Abadie; N Alsayed; M L Brandi; N Burlet; D L Cahall; A Chines; J-P Devogelaer; W Dere; N Goel; N Hughes; J-M Kaufman; S Korte; B H Mitlak; D Niese; R Rizzoli; L C Rovati; J-Y Reginster
Journal:  Osteoporos Int       Date:  2010-03-18       Impact factor: 4.507

2.  Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.

Authors:  Laurence J Hirsch
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

3.  Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity?

Authors:  William L Lanier
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

4.  Regional differences in healthcare delivery for gastroparesis.

Authors:  Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2013-03-24       Impact factor: 3.199

5.  Does the pharmaceutical industry influence guidelines?: two examples from Germany.

Authors:  Gisela Schott; Claudia Dünnweber; Bernd Mühlbauer; Wilhelm Niebling; Henry Pachl; Wolf-Dieter Ludwig
Journal:  Dtsch Arztebl Int       Date:  2013-09-02       Impact factor: 5.594

6.  A tale of too many strengths: Can we minimize prescribing errors and dispensing errors with so many formulations in the market?

Authors:  B Gitanjali
Journal:  J Pharmacol Pharmacother       Date:  2011-07

Review 7.  Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels.

Authors:  Salman Nusrat; Taseen Syed; Sanober Nusrat; Sixia Chen; Wei-Jen Chen; Klaus Bielefeldt
Journal:  JAMA Netw Open       Date:  2018-12-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.